Levobupivacaine Altan Pharma (Levobupivacaine)

Levobupivacaine works by reversibly blocking voltage‑gated sodium channels on nerve membranes. This inhibition prevents the initiation and propagation of action potentials, resulting in loss of sensation and analgesia in the area where the drug is administered.

The dose of levobupivacaine is determined by the prescribing clinician based on the type of procedure, route of administration, patient weight, and clinical condition. Only a qualified health professional should set the appropriate dosage.

Safety data for levobupivacaine in pregnancy and lactation are limited. It should be used only when the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made by the treating physician.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and necessary import documentation.

Levobupivacaine is the S‑enantiomer of bupivacaine and generally offers a similar duration of anesthesia with a lower risk of cardiotoxicity and central nervous system toxicity. Both are amide‑type local anesthetics, but levobupivacaine is often preferred when a safer cardiac profile is desired.

Levobupivacaine should be stored at ambient temperature, protected from light and moisture, and kept in its original sealed container. Avoid freezing and ensure that the solution is not used beyond its expiration date.

Levobupivacaine is administered by a qualified health professional via epidural, intrathecal, or local infiltration injection. The exact technique and volume depend on the intended block, the surgical site, and the patient’s clinical status.

Serious risks include cardiovascular collapse such as cardiac arrest, severe hypotension, bradycardia, central nervous system toxicity leading to seizures, and rare allergic reactions such as anaphylaxis. Immediate medical attention is required if any of these occur.

Levobupivacaine should be avoided in patients with known hypersensitivity to amide‑type local anesthetics, those with severe cardiac conduction disorders, uncontrolled epilepsy, or in situations where a safer alternative is clinically indicated.